Histopathology of telomerase reverse transcriptase promoter (TERT) mutated indeterminate thyroid nodules

Histopathology of telomerase reverse transcriptase promoter (TERT) mutated indeterminate thyroid nodules

Objective: The objective of this study was to analyze the risk of malignancy and the histopathology of telomerase reverse transcriptase promoter (TERT) mutated cytologically indeterminate thyroid nodules (ITN). Methods: A PUBMED search of molecularly tested ITN was conducted and data on TERT mutated...

Full description

Bibliographic Details
Main Authors:	Jessica O. Pinto, Masha J. Livhits, Michael W. Yeh, Atanas Kaykov, Joshua P. Klopper, Richard T. Kloos, Mohammed Alshalalfa, Yangyang Hao, Jing Huang, Mayumi Endo
Format:	Article
Language:	English
Published:	Elsevier 2024-03-01
Series:	Journal of Clinical & Translational Endocrinology
Subjects:	TERT Thyroid nodule Thyroid cancer Molecular markers Indeterminate cytology Systematic review
Online Access:	http://www.sciencedirect.com/science/article/pii/S2214623723000170

Similar Items

Role of Inflammatory Biomarkers (NLR, LMR, PLR) in the Prognostication of Malignancy in Indeterminate Thyroid Nodules
by: Claudio Gambardella, et al.
Published: (2023-03-01)

Uni- and Multivariate Analyses of Cancer Risk in Cytologically Indeterminate Thyroid Nodules: A Single-Center Experience
by: Enrico Battistella, et al.
Published: (2024-02-01)

Indeterminate thyroid nodules in the era of molecular genomics
by: Sarika N. Rao, et al.
Published: (2020-09-01)

Inter-Reader Agreement of ATA Sonographic Risk in Thyroid Nodules with Bethesda Category III Indeterminate Cytology
by: Maria I. Linares Valderrama, et al.
Published: (2021-04-01)

Comparison of S-Detect and thyroid imaging reporting and data system classifications in the diagnosis of cytologically indeterminate thyroid nodules
by: Ling Zhou, et al.
Published: (2023-01-01)

Surgical Management of Indeterminate Thyroid Nodules across Different World Regions: Results from a Retrospective Multicentric (the MAIN-NODE) Study
by: Gian Luigi Canu, et al.
Published: (2023-08-01)

PAPPA Expression in Indeterminate Thyroid Nodules as Screening Test to Select Patients for Molecular Testing
by: Carlotta Marzocchi, et al.
Published: (2022-04-01)

Performance of multigene testing in cytologically indeterminate thyroid nodules and molecular risk stratification
by: Yuanyuan Zhou, et al.
Published: (2023-09-01)

Radiofrequency Ablation of Indeterminate Thyroid Nodules: The First North American Comparative Analysis
by: Peter P. Issa, et al.
Published: (2022-09-01)

Cost-effectiveness analysis of molecular testing for cytologically indeterminate thyroid nodules
by: Navjit Dharampal, et al.
Published: (2022-12-01)

Stratifying Indeterminate Cytology Thyroid Nodules by Combining Thyroid Imaging Reporting and Data Systems (TI-RADS) and The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC)
by: Steve Marlo Cambe, et al.
Published: (2023-11-01)

Thyroid carcinoma‐featured telomerase activation and telomere maintenance: Biology and translational/clinical significance
by: Xiaotian Yuan, et al.
Published: (2022-11-01)

Risk of Complications in Patients Undergoing Completion Thyroidectomy after Hemithyroidectomy for Thyroid Nodule with Indeterminate Cytology: An Italian Multicentre Retrospective Study
by: Gian Luigi Canu, et al.
Published: (2022-05-01)

Pilot Study on the Use of Untargeted Metabolomic Fingerprinting of Liquid-Cytology Fluids as a Diagnostic Tool of Malignancy for Thyroid Nodules
by: Grégoire D’Andréa, et al.
Published: (2023-06-01)

Autonomously functioning thyroid nodules present intermediate malignancy risk according to European Thyroid Imaging Reporting and Data System (EU-TIRADS) and yield indeterminate cytology results
by: Aglaia Kyrilli, et al.
Published: (2023-12-01)

Diagnostic Performance of Afirma and Interpace Diagnostics Genetic Testing in Indeterminate Thyroid Nodules: A Single Center Study
by: Emad Kandil, et al.
Published: (2023-03-01)

Molecular Tests for Risk-Stratifying Cytologically Indeterminate Thyroid Nodules: An Overview of Commercially Available Testing Platforms in the United States
by: Michiya Nishino, et al.
Published: (2021-05-01)

Considerable interobserver variation calls for unambiguous definitions of thyroid nodule ultrasound characteristics
by: Tamas Solymosi, et al.
Published: (2023-03-01)

Reporting Thyroid Cytology in a Globalized World
by: Cristina Pizzimenti, et al.
Published: (2021-09-01)

Risk of malignancy in cytologically indeterminate thyroid nodules harboring thyroid stimulating hormone receptor mutations
by: Dorota Whitmer, et al.
Published: (2022-12-01)

The role of repeat fine needle aspiration in managing indeterminate thyroid nodules
by: Laura Allen, et al.
Published: (2019-03-01)

Clinical features combined with ultrasound characteristics to predict TERT promoter mutations in papillary thyroid carcinoma: a single-center study over the past 5 years
by: Yan Hu, et al.
Published: (2024-03-01)

Significance of RAS Mutations in Thyroid Benign Nodules and Non-Medullary Thyroid Cancer
by: Vincenzo Marotta, et al.
Published: (2021-07-01)

Diagnostic performance of shear wave elastography in thyroid nodules with indeterminate cytology: A systematic review and meta-analysis
by: Yuxuan Qiu, et al.
Published: (2023-10-01)

Performance of the Bethesda System for Reporting Thyroid Cytology in Multi-Institutional Large Cohort of Pediatric Thyroid Nodules: A Detailed Analysis
by: Sule Canberk, et al.
Published: (2022-01-01)

Improved cancer risk stratification of isoechoic thyroid nodules to reduce unnecessary biopsies using quantitative ultrasound
by: Poorani N. Goundan, et al.
Published: (2024-02-01)

Weighty Matters: The Obesity–Thyroid Nodule Connection Unveiling the Impact of Obesity on Thyroid Cancer Risk
by: Saad M. Alqahtani, et al.
Published: (2023-09-01)

The value of routine measurement of serum calcitonin on insufficient, indeterminate, and suspicious thyroid nodule cytology
by: Muhammed Erkam Sencar, et al.
Published: (2022-02-01)

Does a three-degree hypoechogenicity grading improve ultrasound thyroid nodule risk stratification and affect the TI-RADS 4 category? A retrospective observational study
by: Ricardo Luiz Costantin Delfim, et al.
Published: (2023-05-01)

Diagnostic Strategies for Thyroid Nodules Based on Ultrasonographic Findings in Japan
by: Hiroki Shimura, et al.
Published: (2021-09-01)

Initial evaluation of thyroid nodules by primary care physicians and internal medicine residents
by: Celeste C. L. Quianzon, et al.
Published: (2015-04-01)

May 25-31, International thyroid awareness week & May 25, world thyroid day, 2022: Indetermination of indeterminate cytology, aus/flus, fn, susp, in thyroidology?
by: Sengul Ilker, et al.
Published: (2022-09-01)

Risk of malignancy in Thy3 thyroid nodules
by: Rezkallah Emad Mofid Nassif, et al.
Published: (2024-01-01)

Clinico-cytopathological subcategorization in thyroid nodules of atypia of undetermined significance/follicular lesion of undetermined significance using the TIRADS and Bethesda classifications
by: Amirhesam Babajani, et al.
Published: (2023-05-01)

Ultrasound Parameters Can Accurately Predict the Risk of Malignancy in Patients with “Indeterminate TIR3b” Cytology Nodules: A Prospective Study
by: Valentina Guarnotta, et al.
Published: (2023-05-01)

Influence of Care Pathway on Thyroid Nodule Surgery Relevance: A Historical Cohort Study
by: Solène Castellnou, et al.
Published: (2020-07-01)

Reliability of a computer-aided system in the evaluation of indeterminate ultrasound images of thyroid nodules
by: J L Reverter, et al.
Published: (2023-01-01)

Integrated analysis of circulating and tissue proteomes reveals that fibronectin 1 is a potential biomarker in papillary thyroid cancer
by: Guochao Ye, et al.
Published: (2023-05-01)

Fine-needle aspiration cytology and volue of frozen section in the diagnosis of the thyroid nodules
by: Fulya Köybaşıoğlu, et al.
Published: (2004-12-01)

Evaluation of thyroid nodules by ultrasonography with cytological and histopathological correlation
by: Asish Mandal, et al.
Published: (2023-04-01)